Catalyst Wire Dossier Catalyst Wire Dossier

Nintedanib Esylate

Nintedanib Esylate · Macleods Pharmaceuticals Limited
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Nintedanib Esylate, covering 2026-08-03 to 2026-08-19. Get the full timeline:

Most recent: FDA Approved: NINTEDANIB ESYLATE — Original Application (BIOCON PHARMA)

See pricing